Evaluation of two experimental venous thrombosis models in the rat

Thrombosis Research

Volumn 115, Issue 6, 2005, Pages 527-534

  Peternel, Luka ^a,b   Drevenšek, Gorazd ^a   Černe, Manica ^b   Štalc, Anton ^b   Stegnar, Mojca ^c   Budihna, Metka V ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Lek dd   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Experimental model; Hypercoagulability; Rat; Stasis; Venous thrombosis; Vessel injury

Indexed keywords

FERRIC CHLORIDE; NADROPARIN; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMOSTASIS; HYPERCOAGULABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOGENESIS; VEIN THROMBOSIS; VENOUS STASIS;

EID: 15344345124     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.10.007     Document Type: Article

References (15)

1. M.T.G. Vogel, D.G. Meuleman, F.G.M. Bourgondiën, and P.M.J. Hobbelen Comparison of two experimental thrombosis models in rats: effects of four glycosaminoglycans Thromb. Res. 54 1989 399 410
2. J. Lorrain, L. Millet, I. Lechaire, S. Lochot, P. Ferrari, and C. Visconte Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor J. Pharmacol. Exp. Ther. 304 2002 567 574
3. M. Freund, J.P. Cazenave, M. Courtney, E. Degryse, C. Roitssch, and A. Bernat Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats Thromb. Haemost. 63 1990 187 192
4. J.M. Herbert, J.P. Herault, A. Bernat, R.G.M. Amsterdam, J.C. Lormeau, and M. Petitou Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide Blood 91 1998 4197 4205
5. D. Gustafsson, J.E. Nystrom, S. Carlsson, U. Bredberg, U. Eriksson, and E. Gyzander The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects Thromb. Res. 101 2001 171 181
6. E.F. Mammen Pathogenesis of venous thrombosis Chest 102 6 Suppl. 1992 640 644
7. B. Engelmann, T. Luther, and I. Müller Intravascular tissue factor pathway-a model for rapid initiation of coagulation within the blood vessel Thromb. Haemost. 89 2002 3 8
8. I. Talstad Why is the standardization of prothrombin time a problem? Haemostasis 30 2000 258 267
9. J.M. Herbert, A. Bernat, and J.P. Maffrand Importance of platelets in experimental venous thrombosis in the rat Blood 80 1992 2281 2286
10. H. Asakura, Y. Suga, K. Aoshima, Y. Ontachi, T. Mizutani, and M. Kato Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats Crit. Care Med. 30 2002 161 164
11. M.F.W. Festing, and D.G. Altman Guidelines for the design and statistical analysis of experiments using laboratory animals ILAR J. 43 2002 244 258
12. G. Labrecque, and G. Soulban Biological rhythms in the physiology and pharmacology of blood coagulation Chronbiol. Int. 8 1991 361 372
13. M. Cohen, D.J. Simmons, and J.H. Joist Diurnal hemostatic changes in the rat Thromb. Res. 12 1978 965 971
14. H. Emms, and G.P. Lewis Sex and hormonal influences on platelet sensitivity and coagulation in the rat Br. J. Pharmacol. 86 1985 557 563
15. M.A. Orchard, and J.H. Botting The influence of sex hormones on rat platelet sensitivity to adenosine-diphosphate Thromb. Haemost. 46 1981 496 499